Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
Arnold L. Potosky,William W. Davis,Richard M. Hoffman,Janet L. Stanford,Robert A. Stephenson,David F. Penson,Linda C. Harlan +6 more
Reads0
Chats0
TLDR
At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treating with external beam radiotherapy, and the two treatment groups were more similar to each other with respect to overall sexual function.Abstract:
Background Men treated for clinically localized prostate cancer with either radical prostatectomy or external beam radiotherapy usually survive many years with the side effects of these treatments. We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis. Methods The cohort consisted of men aged 55-74 years who were newly diagnosed with clinically localized prostate cancer in 1994-1995 and were treated with radical prostatectomy (n = 901) or external beam radiotherapy (n = 286). We used clinical and quality-of-life data previously collected at the time of diagnosis (i.e., baseline) and at the 2-year follow-up and data newly collected at 5 years after diagnosis to compare urinary, bowel, and sexual function and to examine temporal changes in those functions. Odds ratios (ORs) and adjusted percentages were calculated by logistic regression. All statistical tests were two-sided. Results At 5 years after diagnosis, overall sexual function declined in both groups to approximately the same level. However, at 5 years after diagnosis, erectile dysfunction was more prevalent in the radical prostatectomy group than in the external beam radiotherapy group (79.3% versus 63.5%; OR = 2.5, 95% confidence interval [CI] = 1.6 to 3.8). Approximately 14%-16% of radical prostatectomy and 4% of external beam radiotherapy patients were incontinent at 5 years (OR = 4.4, 95% CI = 2.2 to 8.6). Bowel urgency and painful hemorrhoids were more common in the external beam radiotherapy group than in the radical prostatectomy group. All of these differences remained statistically significant after adjustment for confounders and for differences between treatment groups in some baseline characteristics. Conclusions At 5 years after diagnosis, men treated with radical prostatectomy for localized prostate cancer continue to experience worse urinary incontinence than men treated with external beam radiotherapy. However, the two treatment groups were more similar to each other with respect to overall sexual function, mostly because of a continuing decline in erectile function among the external beam radiotherapy patients between years 2 and 5.read more
Citations
More filters
Journal ArticleDOI
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole,E. David Crawford,Robert L. Grubb,Saundra S. Buys,David Chia,Timothy R. Church,Mona N. Fouad,Edward P. Gelmann,Paul A. Kvale,Douglas J. Reding,Joel L. Weissfeld,Lance A. Yokochi,Jonathan D. Clapp,Joshua M. Rathmell,Thomas L. Riley,Richard B. Hayes,Barnett S. Kramer,Anthony B. Miller,Paul F. Pinsky,Philip C. Prorok,John K. Gohagan,Christine D. Berg +21 more
TL;DR: After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups.
Journal ArticleDOI
Radical prostatectomy versus watchful waiting in early prostate cancer.
Anna Bill-Axelson,Anna Bill-Axelson,Lars Holmberg,Mirja Ruutu,Hans Garmo,Jennifer R. Stark,Jennifer R. Stark,Christer Busch,Stig Nordling,Michael Häggman,Swen-Olof Andersson,Stefan Bratell,Anders Spångberg,Juni Palmgren,Gunnar Steineck,Hans-Olov Adami,Hans-Olov Adami,Jan-Erik Johansson +17 more
TL;DR: Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer, and men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment.
Journal ArticleDOI
Clinical practice guidelines in oncology
William J. Gradishar,Benjamin O. Anderson,Ron Balassanian,Sarah L. Blair,Harold J. Burstein,Amy E. Cyr,Anthony D. Elias,William B. Farrar,Andres Forero,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Steven J. Isakoff,Janice A. Lyons,P. Kelly Marcom,Ingrid A. Mayer,Beryl McCormick,Meena S. Moran,Ruth O'Regan,Sameer A. Patel,Lori J. Pierce,Elizabeth C. Reed,Kilian E. Salerno,Lee S. Schwartzberg,Amy Sitapati,Karen L. Smith,Mary Lou Smith,Hatem Soliman,George Somlo,Melinda L. Telli,John H. Ward,Rashmi Kumar,Dorothy A. Shead +32 more
TL;DR: This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Journal ArticleDOI
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Ian M. Thompson,James Brantley Thrasher,Gunnar Aus,Arthur L. Burnett,Edith D. Canby-Hagino,Michael S. Cookson,Anthony V. D'Amico,Roger Dmochowski,David T. Eton,Jeffrey D. Forman,S. Larry Goldenberg,Javier Hernandez,Celestia S. Higano,Stephen R. Kraus,Judd W. Moul,Catherine M. Tangen +15 more
TL;DR: The Prostate Cancer Clinical Guideline Update Panel is a free resource for clinicians and researchers to assess the need for and ability to evaluate the risks and benefits of utilizing the PSA in men and women diagnosed with prostate cancer.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
Brenda K. Edwards,Martin L. Brown,Phyllis A. Wingo,Holly L. Howe,Elizabeth Ward,Lynn A. G. Ries,Deborah Schrag,Patricia M. Jamison,Ahmedin Jemal,Xiao-Cheng Wu,Xiao-Cheng Wu,Carol Friedman,Linda C. Harlan,Joan L. Warren,Robert N. Anderson,Linda Williams Pickle +15 more
TL;DR: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations.
References
More filters
Journal ArticleDOI
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
John E. Ware,Cathy D. Sherbourne +1 more
TL;DR: A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Journal ArticleDOI
The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.
TL;DR: Findings support the use of the SF-36 survey across the diverse populations studied and identify population groups in which use of standardized health status measures may or may not be problematic.
Journal ArticleDOI
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
TL;DR: In this article, five subclasses defined by the estimated propensity score are constructed that balance 74 covariates, and thereby provide estimates of treatment effects using direct adjustment, and these subclasses are applied within sub-populations, and model-based adjustments are then used to provide estimates for treatment effects within these sub-population.
Journal ArticleDOI
Estimating Causal Effects from Large Data Sets Using Propensity Scores
TL;DR: Propensity score methods generalize subclassification in the presence of many confounding covariates, such as age, region of the country, and sex, in a study of smoking and mortality.
Journal ArticleDOI
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer : The Prostate Cancer Outcomes Study
Janet L. Stanford,Janet L. Stanford,Ziding Feng,Ann S. Hamilton,Frank D. Gilliland,Frank D. Gilliland,Robert A. Stephenson,J. William Eley,Peter C. Albertsen,Linda C. Harlan,Arnold L. Potosky +10 more
TL;DR: This study suggests that radical prostatectomy is associated with significant erectile dysfunction and some decline in urinary function, and these results may be particularly helpful to community-based physicians and their patients with prostate cancer who face difficult treatment decisions.
Related Papers (5)
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Martin G. Sanda,Rodney L. Dunn,Jeff M. Michalski,Howard M. Sandler,Laurel L. Northouse,Larry Hembroff,Xihong Lin,Thomas K. Greenfield,Mark S. Litwin,Mark S. Litwin,Christopher S. Saigal,Arul Mahadevan,Eric A. Klein,Adam S. Kibel,Louis L. Pisters,Deborah A. Kuban,Irving D. Kaplan,Darien Wood,Jay P. Ciezki,Nikhil L. Shah,John T. Wei +20 more